¼±Åà - È­»ìǥŰ/¿£ÅÍŰ ´Ý±â - ESC

 
"multiple drug resistant tuberculosis"¿¡ ´ëÇÑ °Ë»ö °á°úÀÔ´Ï´Ù. °Ë»ö °á°ú º¸´Â µµÁß¿¡ Tab ۸¦ ´©¸£½Ã¸é °Ë»ö âÀÌ ¼±Åõ˴ϴÙ.
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
¿µ¹® tuberculosis ÇÑ±Û °áÇÙ
¼³¸í   
  °áÇÙ±Õ¿¡ ÀÇÇÑ »ç¶÷À̳ª µ¿¹°ÀÇ °¨¿°À¸·Î¼­, °áÀýÇü¼º°ú Á¶Á÷ÀÇ Ä¡Á»ç(caseation necrosis)°¡ Æ¯Â¡ÀÌ´Ù. ÁֵȠ¿øÀαÕÀº Mycobacterium tuberculosis, M. bovis, M. avium, M. kansasii¿Í ±âŸ ºÐ·ùµÇÁö ¾ÊÀº ºñÀüÇüÀÇ ¹ÌÄÚ¹ÚÅ×·ýµµ ¿øÀαÕÀÌ µÈ´Ù. ÀüÇüÀûÀΠÁúº´°ú´Â ÀÓ»óÀûÀ¸·Îµµ ÇüÅÂÇÐÀûÀ¸·Îµµ ±¸º°ÇÒ ¼ö ¾ø´Â ºñÁ¤Çü°¨¿°Àº, »ç¶÷¿¡¼­ »ç¶÷À¸·Î Á÷Á¢ °¨¿°À» ÀÏÀ¸Å°´Â °ÍÀ¸·Î »ý°¢µÇÁö ¾Ê´Â´Ù. °áÇÙÁõÀº ±× Áõ»óÀÇ ¹ßÇö¿¡ À־ë´ÜÈ÷ ´Ù¾çÇϸ砸¸¼ºÈ­µÇ±â ½±´Ù. ¸ðµç Àå±â¿¡ °¨¿°ÀÌ ÀϾÁö¸¸, »ç¶÷¿¡ À־´Â ÁַΠÆó°¡ Ä§¹üµÇ¸ç, ±×°÷À¸·ÎºÎÅÍ Ç÷°ü°ú ¸²ÇÁ°üÀ» ÅëÇØ ´Ù¸¥ Àå±â¿¡ °¨¿°µÈ´Ù. Áõ»óÀº ¿ÀÈÄÀÇ ¹Ì¿­°ú ¼ö¸éÁßÀÇ °¡º­¿î ½ÄÀº ¶¡ µî°ú ÇÔ²² Ä§¹üµÈ Àå±âÀÇ ±â´É ÀúÇÏ¿¡ µû¸¥ Áõ»óÀÌ µ¿¹ÝµÈ´Ù. Ä¡·á´Â Ç×°áÇÙÁ¦ÀÇ Àå±â°£, ÁýÁßÀûÀΠÅõ¿©À̸ç Çʿ信 µû¶ó¼­´Â ¼ö¼úÀ» Çϱ⵵ ÇÑ´Ù.
¿µ¹® Mycobacterium tuberculosis ÇÑ±Û °áÇÙ±Õ
¼³¸í   
  ¹ÌÄÚ¹ÚÅ×·ý¼ÓÀÇ »ç¶÷ °áÇÙÀ» ÀÏÀ¸Å°´Â ±ÕÀÌ´Ù. 1882³â ÄÚÈå(Koch)¿¡ ÀÇÇØ ¹ß°ßµÇ¾ú´Ù. ±×·¥¾ç¼º »ê¼Ò¼º ¸·´ë±ÕÀ̸ç 0.3~0.6¡¿2~4¥ìm, ¹«¾ÆÆ÷, Ç׻꼺ÀÌ´Ù. Ç×»ê, Ç×¾ËÄ®¸®, Ç×¾ËÄÚ¿Ã, ¼Òµ¶Á¦¿¡ ÀúÇ×ÇÑ´Ù. ÀúÇ׷°ú ¹ø½Ä·ÂÀÌ °­ÇÏ¿© Àü¿°¼ºÀÌ ³ôÀ¸³ª °ÇÁ¶, ¿­, ÇÞºû¿¡´Â ¾àÇÏ´Ù. ¼¼Æ÷º®¿¡´Â ´Ù·®ÀÇ Áö¹æÁúÀÌ Æ÷ÇԵǾî ÀÖ´Ù. ´Ï¾Æ½Å°Ë»ç´Â »ç¶÷Çü °áÇÙ±Õ¸¸ ¾ç¼ºÀ̸ç À̰ÍÀº °¨º°¿¡ µµ¿òÀÌ µÈ´Ù. °¨¿°Àº ºñ¸»°¨¿°ÀÌ°í Æó°áÇÙÀÌ ¸¹Áö¸¸ Ç÷Çà ¼Ó¿¡ µé¾î°¡¸é ¸ðµç Àå±â¿¡ °áÇÙÀ» ÀÏÀ¸Å²´Ù. Æ¯À¯ÇÑ °áÇÙ°áÀýÀ» Çü¼ºÇÑ´Ù. °áÇÙÀÇ Áø´Ü¿¡´Â Æ®º£¸£Ä𸰠¹ÝÀÀÀÌ »ç¿ëµÇ¸ç ¿¹¹æ¿¡´Â ºñ¾¾Áö(BCG) Á¢Á¾ÀÌ ½Ç½ÃµÈ´Ù. ¸é¿ªÀº ¼¼Æ÷¼º ¸é¿ªÀ̸ç Å«Æ÷½Ä¼¼Æ÷ÀǠȰ¼ºÈ­·Î ÀÎÇØ ±ÕÀÇ Áõ½ÄÀÌ ¾ïÁ¦µÈ´Ù.
¿µ¹® multiple sclerosis ÇÑ±Û ´Ù¹ß°æÈ­Áõ
¼³¸í   
  ½Å°æÃà»èÀ» µÑ·¯½Î°í Àִ ¸»ÀÌÁý(myelin sheath)ÀÇ ÆÄ±«·Î ÀÎÇÑ º´Àû»óŸ¦ ¸»ÇÔ. ÆÄ±«µÈ ¸»ÀÌÁýÀº ÈäÅ͸¦ ³²±â°Ô µÇ¾î ½Å°æÃà»èÀ» ÅëÇÑ ½Å°æÀü´ÞÀÌ Á¦´ë·Î µÇÁö ¾Ê¾Æ ¿îµ¿, °¨°¢, ÀÚÀ²½Å°æ ¸ðµÎÀÇ ½Å°æÀü´ÞÀå¾Ö°¡ ³ªÅ¸³­´Ù. ÀÌ º´Åʹ ¾îµð¼­³ª ³ªÅ¸³¯ ¼ö À־ ±× Àå¾Ö°¡ ³ªÅ¸³ª´Â ºÎÀ§¿¡ µû¶ó ¼­·Î ´Ù¸¥ Áõ»óÀ» È£¼ÒÇÑ´Ù.
¿µ¹® multiple myeloma ÇÑ±Û ´Ù¹ß°ñ¼öÁ¾
¼³¸í   
  ´Ù¹ß¼º ¿ø¹ß¼º°ñÁ¾¾ç. ¸Ó¸®»À-°¥ºñ»À-º¹Àå»À-ôÃß»À-°ñ¹Ý µî¿¡ Àß ³ªÅ¸³ª°í, ¹°··¹°··ÇÑ Á¾±«¸¦ Çü¼ºÇϸç, »ÀÀÇ Èí¼ö°¡ ÀϾ°í, 40~60¼¼ ³²ÀÚ¿¡°Ô ¸¹ÀÌ ¹ß»ýÇÑ´Ù. °ñ¼öÁ¾ Á¾¾ç¼¼Æ÷´Â ÇüÁú¼¼Æ÷¿¡¼­ À¯·¡ÇÑ °ÍÀ̾ ÇüÁú¼¼Æ÷Á¾À̶ó°íµµ ÇÑ´Ù. °ú°Å¿¡´Â ÇüÁú¼¼Æ÷¼º°ñ¼öÁ¾ À̿ܿ¡´Â ´Ù¸¥ °ñ¼öÁ¶Ç÷¿ä¼Ò¿¡¼­ »ý±â´Â °ñ¼öÁ¾À̶ó°í »ý°¢ÇßÁö¸¸ ÇöÀç´Â ºÎÁ¤µÇ°í ÀÖ´Ù. ÇüÁú¼¼Æ÷´Â ¿ø·¡ ¸é¿ª±Û·ÎºÒ¸°À» »ý»êÇϴ ¼¼Æ÷À̸ç, ±×°ÍÀÌ Á¾¾çÈ­ÇÑ ´Ù¹ß °ñ¼öÁ¾ È¯ÀÚ¿¡¼­µµ ´ëºÎºÐ Ç÷û ¼Ó¿¡ ¸é¿ª ±Û·ÎºÒ¸°ÀÌ Áõ°¡µÈ °ÍÀ» º¼ ¼ö ÀÖ´Ù. Áõ°¡ÇÑ ±Û·ÎºÒ¸°Àº IgG³ª IgAÀΠ°æ¿ì°¡ ¸¹Áö¸¸ ´Ù¸¥ Çüµµ ÀÖ´Ù. °ñ¼öÁ¾ È¯ÀÚ ¾à 50%´Â ¿ÀÁÜ¿¡¼­ º¥½ºÁÔ½º´Ü¹éÁúÀÌ °ËÃâµÇ´Âµ¥, ÀÌ ´Ü¹éÁúÀÇ ÃàÀû¿¡ ÀÇÇØ ¿ä¼¼°üÀÌ ÆÄ±«µÇ°í, ÄáÆÏ°æÈ­°¡ ÀϾ´Ù. °ñ¼öÁ¾ È¯ÀÚ¿¡¼­´Â Ç÷û´Ü¹é ÀÌ»óÀ¸·Î °¡²û ¾Æ¹Ð·ÎÀ̵åÁõÀÌ ³ªÅ¸³­´Ù. »À X¼± ¼Ò°ßÀ¸·Î¼­´Â µµ·Á³½ º´ÅÍ, °ñÀ¶ÇØ»ó, º´Àû°ñÀýÀÌ °üÂûµÈ´Ù.
¿µ¹® multiple personality ÇÑ±Û ´ÙÀμº ÀΰÝ
¼³¸í   
  Çظ®¼º Á¤½ÅÀå¾ÖÀÇ Çϳª·Î ³ªÅ¸³­´Ù. ÇÑ »ç¶÷ÀÌ ¿©·¯ »ç¶÷ÀÇ ¼º°ÝÀ» ¼ÒÀ¯Çϰí Àִ °ÍÀ¸·Î ¸¶Ä¡ ¡°Áöų¹Ú»ç¿Í ÇÏÀ̵堾¾¡±¿Í °°Àº °æ¿ìÀÌ´Ù. ¾Æ¸¶, ÇöÀç ÀÚ½ÅÀǠóÁö¿¡¼­ ¹þ¾î³ª°í ½ÍÀº ¹«ÀǽÄÀûÀΠ¿å¸Á¿¡¼­ ºñ·ÔµÇ´Â °ÍÀ¸·Î ¿©°ÜÁø´Ù.
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • drug resistant bacterium
    ¾àÁ¦³»¼º±Õ
  • drug-resistant
    ¾à¹°ÀúÇ×-
  • multiple drug resistance
    ´Ù¾àÁ¦³»¼º, ¿©·¯¾àÀúÇ×
  • insulin-resistant diabetes
    Àν¶¸°ÀúÇ×´ç´¢º´
  • vitamin D-resistant rickets
    ºñŸ¹ÎDÀúÇ×±¸·çº´
  • active tuberculosis
    Ȱµ¿°áÇÙ
  • acute tuberculosis
    ±Þ¼º°áÇÙ
  • aerogenic tuberculosis
    ÈíÀÔ°áÇÙ
  • bovine tuberculosis
    ¿ìÇü°áÇÙ
  • caseous tuberculosis
    Ä¡Áî°áÇÙ
  • disseminated tuberculosis
    ÆÄÁ¾°áÇÙ
  • endogenous tuberculosis
    ³»ÀΰáÇÙ
  • fibrosing tuberculosis
    ¼¶À¯È­°áÇÙ
  • hematogenous tuberculosis
    Ç÷Ç༺°áÇÙ
  • incipient tuberculosis
    Ãʱâ°áÇÙ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • multiple birth
    ´Ù»ê, ´ÙÅÂÃâ»ê
  • plural multiple birth
    ´Ù»ê, ´ÙÅÂÃâ»ê
  • Mycobacterium tuberculosis
    °áÇÙ±Õ
  • multiple
    ´Ù¹ß-, ¿©·¯-, ¹µ-, ´Ù-
  • multiple myeloma
    ´Ù¹ß°ñ¼öÁ¾
  • multiple endocrine neoplasia
    º¹ÇÕ³»ºÐºñ»ù½Å»ý¹°
  • multiple sclerosis
    ´Ù¹ß°æÈ­Áõ
  • tuberculosis
    °áÇÙ
  • disseminated tuberculosis
    ÆÄÁ¾°áÇÙ
  • intestinal tuberculosis
    âÀÚ°áÇÙ
  • miliary tuberculosis
    Á¼½Ò°áÇÙ
  • multiple causation theory
    Áúº´¹ß»ý´Ù¿äÀμ³
  • pulmonary tuberculosis
    Æó°áÇÙ
  • renal tuberculosis
    ÄáÆÏ°áÇÙ, ½ÅÀå°áÇÙ
  • drug
    ¾à, ¾à¹°, ¾àÁ¦
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • drug resistant bacterium
    ¾àÁ¦³»¼º±Õ
  • insulin-resistant diabetes
    Àν¶¸°ÀúÇ×´ç´¢º´
  • vitamin D-resistant rickets
    ºñŸ¹ÎµðÀúÇ×±¸·íº´
  • multiple drug resistance
    ´Ù¾àÁ¦³»¼º, ¿©·¯¾àÀúÇ×
  • active tuberculosis
    Ȱµ¿°áÇÙ
  • aerogenic tuberculosis
    (¢¡inhalation tuberculosis) ÈíÀÔ°áÇÙ
  • caseous tuberculosis
    °Ç¶ô°áÇÙ
  • disseminated tuberculosis
    ÆÄÁ¾°áÇÙ
  • endogenous tuberculosis
    ³»ÀΰáÇÙ
  • fibrosing tuberculosis
    ¼¶À¯È­°áÇÙ
  • hematogenous tuberculosis
    Ç÷Çà°áÇÙ
  • incipient tuberculosis
    Ãʱâ°áÇÙ
  • inhalation tuberculosis
    ÈíÀÔ°áÇÙ
  • latent tuberculosis
    Àẹ°áÇÙ
  • Mycobacterium tuberculosis
    °áÇÙ±Õ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • OTC drug : over-the-counter drug
    ÀϹݸžà.
  • Cowdens syndrome = multiple hamartoma syndrome
    ´Ù¹ß¼º °ú¿ÀÁ¾ ÁõÈıº
  • MOTSA (multiple overlapping thin-slab acquisition)
    ´ÙÁß Áߺ¹ ¼¼ÆíÆÇ ȹµæ
  • infection, multiple
    ´ÙÁß°¨¿°, º¹¼ö±Õ°¨¿°
  • infectious multiple gangrene of skin
    Àü¿°¼º ÇǺΠ´Ù¹ß¼º ±«Àú
  • personality disorder, multiple
    ´ÙÁß(Òýñì) ÀΰÝÀå¾Ö
  • personality, multiple
    ´ÙÁßÀΰÝ.
  • plural birth =multiple b.
    ´Ùźи¸(Òý÷à ÝÂØ´).
  • Mycobacterium tuberculosis
    °áÇÙ±Õ
  • Mycobacterium tuberculosis
    °áÇÙ±Õ.
  • Mycobacterium tuberculosis
    °áÇÙ±Õ.
  • Mycobacterium tuberculosis
    °áÇÙ±Õ.
  • Mycobacterium tuberculosis var. avium
    Á¶Çü°áÇÙ±Õ.
  • Mycobacterium tuberculosis var. avium bovis
    ¿ìÇü°áÇÙ±Õ.
  • Mycobacterium tuberculosis var. hominis
    ÀÎÇü°áÇÙ±Õ.
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • bacterium, drug resistant
    ¾àÁ¦³»¼º¼¼±Õ
  • drug resistant bacterium
    ¾àÁ¦³»¼º¼¼±Õ
  • insulin-resistant diabetes
    Àν¶¸°ÀúÇ×¼º ´ç´¢º´.
  • resistant ovary syndrome
    ¹«¹ÝÀÀ ³­¼Ò ÁõÈıº
  • tartarate-resistant acid phosphatase
    ÁÖ¼®»ê¿°ÀúÇ×¼ºÀλêÈ¿¼Ò
  • tartrate resistant acid phosphatase
    ŸŸ¸£»ê¿°³»¼º »ê¼º Æ÷½ºÆÄŸÁ¦
  • vitamin D resistant osteomalacia
    ºñŸ¹ÎD ÀúÇ×¼º°ñ¿¬È­(Áõ)(¡­î½ù÷àõÍéæãûù ñø).
  • vitamin D resistant rickets
    ºñŸ¹ÎDÀúÇ×¼º±¸·çº´(¡­ ׬ܻ).
  • vitamin d resistant osteomalacia
    ºñŸ¹ÎDÀúÇ×¼º°ñ¿¬È­(Áõ)(¡­î½ù÷àõÍéæãûùñø)
  • vitamin d resistant rickets
    ºñŸ¹ÎDÀúÇ×¼º±¸·çº´(¡­±¸×¬Ü»)
  • multiple drug resistance
    ´ÙÁ¦³»¼º
  • multiple drug resistance gene
    º¹ÇÕ¾àÁ¦³»¼ºÀ¯ÀüÀÚ
  • drug dependence ; drug dependency
    ¾à¹°ÀÇÁ¸(¼º).
  • active tuberculosis
    Ȱµ¿¼º °áÇÙ(Áõ)(üÀÔÑàõÌ¿ú·ñø).
  • adrenal tuberculosis
    ºÎ½Å°áÇÙ(Áõ).
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 3 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • Multiple placenta
    ¹µÅ¹Ý
    [¿¾ ¿ë¾î] ´Ù¹ß¼ºÅ¹Ý
  • Multiple deformity
    º¹ÇÕ±âÇü
    [¿¾ ¿ë¾î] ´Ù¹ß¼º±âÇü
  • Multiple morphologic defect
    º¹ÇÕÇüŰáÇÔ
    [¿¾ ¿ë¾î] ´Ù¹ß¼ºÇüÅÂÇÐÀû°áÇÔ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 4 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • antiamebic drug
    ¾Æ¸Þ¹Ù±¸ÃæÁ¦
  • antimalarial drug
    Ç׸»¶ó¸®¾ÆÁ¦
  • multiple budding
    ´Ù¼öÃâ¾Æ
  • multiple fission
    ´ÙºÐ¿­
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • vitamin D-resistant rickets
    ºñŸ¹Î D ÀúÇ×¼º(î½ù÷àõ) ±¸·çº´(±¸·çÜ»)
  • multiple alleles
    º¹´ë¸³À¯ÀüÀÚ(ÜÜÓߨ¡ë¶îîí­)
  • multiple binding
    ´ÙÁß°áÇÕ(ÒýñëÌ¿ùê)
  • multiple codon recognition
    ´Ù(Òý)ÄÚµ· ÀÎÁö(ìãò±)
  • multiple displacement mechanism
    ´Ù(Òý)´ëü(ÓÛôð) ±âÀü(Ѧï®)
  • multiple factor hypothesis
    ´ÙÀÎÀÚ¼³(Òýì×í­àã)
  • multiple gene
    ´ÙÀ¯ÀüÀÚ(Òýë¶îîí­)
  • multiple inhibition analysis
    ´ÙÁß(Òýñì)ÀúÇØ ºÐ¼®(îÁúªÝÂà°)
  • drug-detoxication enzyme
    ¾à¹°Çص¶ È¿¼Ò(å·Úªú°Ô¸ý£áÈ) (ÔÒ) drug-metabolizing enzyme
  • drug-metbolizing enzyme
    ¾à¹°´ë»ç È¿¼Ò(å·ÚªÓÛÞóý£áÈ)
  • drug resistance
    ¾à¹° ÀúÇ×(å·Úªî½ù÷)
  • drug-resistance plasmid
    ¾à¹°ÀúÇ×(å·Úªî½ù÷) Çö󽺹̵å (ÔÒ) R plasmid
  • narcotic drug
    ¸¶¾à(ئå·)
  • psychedelic drug
    ȯ°¢Á¦(ü³ÊÆð¥)
  • radiomimetic drug
    ¹æ»ç¼± ¾ç(À¯»ç) ¾à¹°(Û¯ÞÒàÊåÆ(ëºÞÄ)å·Úª)
KI ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • drug
    ¾à, ¾à¹°, ¾àÁ¦
  • drug abuse
    ¾à¹°³²¿ë
  • narcotic drug
    ¸¶¾à
  • tuberculostatic drug
    Ç×°áÇÙ¾à
  • hematogenous tuberculosis
    Ç÷Ç༺°áÇÙ
  • miliary tuberculosis
    ¼Ó¸³¼º°áÇÙ(Áõ)
  • primary tuberculosis
    ÀÏÂ÷°áÇÙ(Áõ), Ãʱâ°áÇÙ(Áõ)
  • pulmonary tuberculosis
    Æó°áÇÙ
  • secondary tuberculosis
    ÀÌÂ÷¼º°áÇÙ
  • tuberculosis
    °áÇÙ(Áõ)
  • MOTSA [=multiple overlapping thin-slab acquisition]
    ´ÙÁßÁߺ¹¼¼ÆíÆÇȹµæ
  • multiple
    ´Ù¹ß¼º
  • multiple cranial nerve palsy
    ´Ù¹ß¼º³ú½Å°æ¸¶ºñ
  • multiple echo
    ´ÙÁß¿¡ÄÚ
  • multiple epiphyseal dysplasia
    ´Ù¹ß¼º°ñ´ÜÀÌÇü¼ºÁõ
KMLE ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
CR calculation rate; calculus removed; calorie-restricted; cardiac rehabilitation; cardiac resuscitatio...
ECG Electro-Cardio-Graphy(-Gram); ½ÉÀüµµ
   = EKG
  1. Conducting System Structu...
SR sarcoplasmic reticulum; saturation recovery; scanning radiometer; screen; secretion rate; sedimentat...
MDR TB multidrug-resistant tuberculosis
DA dark adaptation; dark agouti [rat]; daunomycin; degenerative arthritis; delayed action; Dental Assis...
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü À¯»ç °Ë»ö °á°ú : 5 ÆäÀÌÁö: 1
MDR-TB Multi-drug resistant tuberculosis
MDR multiple drug resistant
M. tuberculosis Mycobacterium tuberculosis
MDR Multi-drug resistant
MDR Multiple Drug Resistance
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
  • multiple fission,multiple division
    ´Ù ºÐ¿­
    1°³ÀÇ ¸ð¼¼Æ÷°¡ ÀϽÃÀûÀ¸·Î ´Ù¼öÀÇ µþ ¼¼Æ÷·Î ³ª´©¾îÁö´Â ÀÏ. º¹ ºÐ¿­À̶ó°íµµ ÇÑ´Ù. ¸ðü°¡ 2°³ÀÇ µþ °³Ã¼·Î ³ª´©¾îÁö´Â 2ºÐ¿­¿¡ ´ëÇÏ¿© ÀϽÿ¡ ´Ù¼öÀÇ µþ °³Ã¼·Î ºÐ¿­ÇÏ´Â Çö»óÀ» ¸»ÇÑ´Ù. ¿ø»ýµ¿¹° Æ÷ÀÚÃæ·ùÀÇ Áõ¿ø»ý½Ä µî¿¡¼­ º¼ ¼ö ÀÖ´Ù. Áï, ÇÙ¸¸ÀÌ ºÐ¿­À» µÇÇ®ÀÌÇÏ¿© ´ÙÇÙü°¡ µÈ µÚ¿¡ ¼¼Æ÷ÁúÀÌ ÀÏÁ¦È÷ ºÐ¿­ÇÏ¿© °¢°¢ ÇÙ 1°³¾¿À» ÇÔÀ¯ÇÏ´Â µþ °³Ã¼·Î ³ª´©¾îÁø´Ù.
  • multiple drug misuse
    ¿©·¯ ¾à¹°ÀÇ ¿À¿ë
  • multiple drug resistance gene
    º¹ÇÕ ¾àÁ¦ ³»¼º À¯ÀüÀÚ
  • chloride resistant
    ¿°¼Ò¿¡ °­ÇÑ
  • PCN-resistant-lactam antibiotics

    PDGF (Ç÷¼ÒÆÇ À¯·¡ ¼ºÀå ÀÎÀÚ

  • penicillinase-resistant penicillin
    Æä´Ï½Ç¸° ºÐÇØ È¿¼Ò ³»¼º Æä´Ï½Ç¸°
    Ãø¼â¸¦ º¯È­½ÃÄÑ Ç×±ÕÈ¿°ú´Â ±×´ë·Î À¯ÁöÇϸ鼭 º£Å¸¶ôŽ ºÐÇØ È¿¼Ò¿¡ ÀÇÇØ º£Å¸¶ôŽ °í¸®°¡ ÆÄ±«µÇ´Â °ÍÀ» ¹æÁöÇÑ ¹ÝÇÕ¼º Æä´Ï½Ç¸° Á¦Á¦·Î ¸ÞŸ½Ç¸°, ³ªÇÁ½Ç¸°, isoxazolyl
  • resistant
    ÀúÇ×¼º, ÀúÇ×Àû, ÀúÇ×ÇÏ´Â, ÀúÇ×¼ºÀÇ, ³»¼ºÀÇ
    ÀúÇ×·ÂÀ» ¸¸µé°Å³ª °¡Áö´Â.
  • resistant lateral exercise
    Ãø¹æ ÀúÇ× ¿îµ¿
  • resistant protrusive movement
    Àü¹æ ÀúÇ× ¿îµ¿
  • vit D-resistant rickets
    D-ÀúÇ×¼º ±¸·çº´
  • vitamin D resistant osteomalacia
    ºñŸ¹ÎD ÀúÇ×¼º °ñ¿¬È­, ºñŸ¹ÎD ÀúÇ×¼º °ñ¿¬È­Áõ
  • active tuberculosis
    Ȱµ¿¼º °áÇÙ, Ȱµ¿¼º °áÇÙÁõ
    ȯÀÚ¿¡¼­ ±ÕÀÌ °ËÃâµÇ´Â »óÅ¿¡ ÀÖ´Â °áÇÙ.
  • adrenal tuberculosis
    ºÎ½Å °áÇÙ, ºÎ½Å °áÇÙÁõ
  • adult tuberculosis
    ¼ºÀÎ °áÇÙ, ¼ºÀÎÇü °áÇÙ
  • aerogenic tuberculosis
    ÈíÀÔ¼º °áÇÙ, ÈíÀÔ¼º °áÇÙÁõ
CancerWEB ¿µ¿µ ÀÇÇлçÀü ¸ÂÃã °Ë»ö °á°ú : 1 ÆäÀÌÁö: 1
multiple drug resistant tuberculosis A strain of TB that does not respond to two or more standard anti-TB drugs. MDR-TB usually occurs when treatment is interrupted thus allowing mutations in the organism to occur that confer drug resistance.
(09 Oct 1997)
CancerWEB ¿µ¿µ ÀÇÇлçÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
tuberculosis, multidrug-resistant Tuberculosis resistant to chemotherapy with two or more antitubercular agents. The problem of resistance is particularly troublesome in tuberculosis as an opportunistic disease in HIV infection.
(12 Dec 1998)
drug resistant Unresponsive to the desired effects of drugs or other therapy for example: irradiation cytotoxic agents or hormones. Drug resistance of cells within tumours is probably the major cause of treatment failure.
(16 Dec 1997)
drug resistance, multiple Simultaneous resistance to a broad spectrum of structurally and functionally distinct drugs following exposure to a single agent. It is thought to result from the overexpression of genes encoding an integral plasma membrane protein, p-glycoprotein.
(12 Dec 1998)
drug-drug interaction The effects that occur when two or more drugs are used together. Such effects include changes of absorption in the digestive tract, changes in rate of the drugs' breakdown in the liver, new or enhanced side effects and changes in the drugs' activity.
(09 Oct 1997)
antibiotic-resistant Indicating microorganisms that continue to multiply although exposed to antibiotic agents.
(05 Mar 2000)
vancomycin resistant enterococcus A form of intestinal bacteria (formerly classed under streptococcus faecalis) which is not sensitive to the big gun antibiotic, vancomycin. This organism is usually only fatal in those who are, for reasons of age or infirmity, immunosuppressed. The pathology of the illness is exacerbated when haemosepsis (blood-stream infection) develops.
(09 Oct 1997)
vasopressin-resistant diabetes Diabetes insipidus due to inability of the kidney tubules to respond to antidiuretic hormone; X-linked inheritance, with full expression in males and partial defect in heterozygous females.
Synonym: vasopressin-resistant diabetes.
(05 Mar 2000)
vitamin d-resistant rickets <radiology> X-linked recessive, defect in renal tubular resorption of phosphate, presents at 1 yr, progressive limb deformities X-ray: less severe changes than other rickets, presents later Differential diagnosis features: family hx, normal serum calcium, marked hypophosphataemia (decreased PO4), no secondary hyperparathyroidism
(12 Dec 1998)
resistant Making or having powers of resistance, resisting.
(18 Nov 1997)
resistant ovary syndrome <syndrome> An obsolete term for amenorrhoea associated with hypergonadotrophism and normal ovarian follicles.
Synonym: resistant ovary syndrome.
Origin: after the surname of the first reported patient
(05 Mar 2000)
tartrate-resistant acid phosphatase <biochemistry, enzyme> Acid phosphatase is present in bone, prostate, platelets, erythrocytes and spleen.
Osteoclasts contain an isoenzyme that is resistant to tartrate, whereas, the isoenzyme in the prostate is sensitive. Tartrate-resistant acid phosphatase is elevated in the serum of patients with primary hypoparathyroidism, Paget disease, vertebral osteoporosis, T-cell lymphoma and in women after oophorectomy. Oestrogen replacement in osteoporotic postmenopausal women is associated with a decrease in tartrate-resistant acid phosphatase of 70% over 3 to 6 months.
Acronym: TRAP
(16 Dec 1997)
ketosis-resistant diabetes Type II or adult onset diabetes mellitus, in which episodes of ketoacidosis rarely occur.
(05 Mar 2000)
acute miliary tuberculosis A rapidly fatal disease due to the general dissemination of tubercle bacilli in the blood, resulting in the formation of miliary tubercles in various organs and tissues, and producing symptoms of profound toxaemia.
Synonym: acute miliary tuberculosis, disseminated tuberculosis.
(05 Mar 2000)
acute tuberculosis A rapidly fatal disease due to the general dissemination of tubercle bacilli in the blood, resulting in the formation of miliary tubercles in various organs and tissues, and producing symptoms of profound toxaemia.
Synonym: acute miliary tuberculosis, disseminated tuberculosis.
(05 Mar 2000)
adult tuberculosis Tuberculosis found in adults and characterised by lesions near the apex of an upper lobe, which may cavitate or heal with scarring without spreading to lymph nodes; theoretically, secondary tuberculosis may be due to exogenous reinfection or to reactivation of a dormant endogenous infection.
Synonym: adult tuberculosis, postprimary tuberculosis, reinfection tuberculosis.
(05 Mar 2000)
ÇÑ¿µ/¿µÇÑ »çÀü À¯»ç °Ë»ö °á°ú : 15 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
  • tuberculosis
    °áÇÙ
  • pulmonary tuberculosis
    Æó°áÇÙ
  • tuberculosis
    (Æó)°áÇÙ
  • resistant
    ÀúÇ×ÇÏ´Â
  • crease-resistant
    (¿Ê°¨ÀÌ)±¸°ÜÁöÁö ¾Ê´Â
  • fire resistant
    ³»È­¼ºÀÇ
  • resistant,-tent
    ÀúÇ×ÇÏ´Â;¹æÁöÇÏ´Â;¹æÇØÇÏ´Â;ÀúÇ×·ÂÀÌ ÀÖ´Â;³»...ÀÇ;...ÇÑ ÀúÇ×·ÂÀÌÀÖ´Â;ÀúÇ×ÀÚ;¹Ý´ëÀÚ;·¹Áö½ºÅÁ½ºÀÇ ÀÏ¿ø;¹æ¿°Á¦
  • common multiple
    °ø¹è¼ö
  • multiple
    º¹ÇÕÀÇ;´Ù¾çÇÑ;¹è¼öÀÇ;¹è¼ö;¹è¼ö·®(least common multiple ÃÖ¼Ò °ø¹è¼ö)
  • multiple choice test
    ¼±´ÙÇü Å×½ºÆ®
  • multiple cropping
    ´Ù¸ðÀÛ
  • multiple farming
    ´Ù°¢ ³ó¾÷
  • multiple shop
    ¿¬¼âÁ¡
  • Food and Drug Administration
    ½Äǰ ÀǾ౹(º¸°Ç ±³À° º¹Áö¼ºÀÇ ÀϺÎ)
  • combination drug
    º¹ÇÕ¾à(2Á¾ ÀÌ»óÀÇ Ç×»ý ¹°Áú µîÀÇ È¥ÇÕ¾à)
ÀÌ ¾Æ·¡ ºÎÅÍ´Â °á°ú°¡ ¾ø½À´Ï´Ù.
KMLE ¾àǰ/ÀǾàǰ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
KMLE ¾àǰ/ÀǾàǰ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • Á¦Ç°¸í
    ¼ººÐ/ÇÔ·®
    ±¸ºÐ/º¸Çè±Þ¿©
¾Ë±â½¬¿î ÀÇÇпë¾îÇ®ÀÌÁý, ¼­¿ïÀÇ´ë ±³¼ö ÁöÁ¦±Ù, °í·ÁÀÇÇÐ ÃâÆÇ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÀÇÇù Çʼö ÀÇÇпë¾îÁý »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 2 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
¿¾ ´ëÇÑÀÇÇù 3 ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑÇØºÎÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѽŰæ¿Ü°úÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ÇÑÀÚ
´ëÇѱâ»ýÃæÇÐȸ ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
´ëÇÑ»ýÈ­ÇкÐÀÚ»ý¹°ÇÐȸ ¿ë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KI ÀÇÇпë¾î »çÀü °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
KMLE ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE ÀÚµ¿ÃßÃâ ÀÇÇоà¾î »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÀÇÇÐ³í¹® ¾àÀÚ(Pubmed/Entrez) °Ë»ö ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
Çѱ¹Ç¥ÁØÁúº´»çÀκзù ¾àÀÚ À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ÄÚµå
    ¿µ¹®
    ÇѱÛ
°æºÏ´ë Ä¡°ú´ëÇÐ ±¸°­³»°ú ±³½Ç »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
    ¼³¸í
MeSH(Medical Subject Headings) ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
MeSH(Medical Subject Headings) À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü ¸ÂÃã °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Merriam-Webster's ÀÇÇлçÀü À¯»ç °Ë»ö (https://www.merriam-webster.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - A.D.A.M. Medical Encyclopedia À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics ¸ÂÃã °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - MedlinePlus Health Topics À¯»ç °Ë»ö (http://www.nlm.nih.gov) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ ¸ÂÃã °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - µå·¯±×ÀÎÆ÷ ¾àÇÐ Á¤º¸ À¯»ç °Ë»ö (http://www.druginfo.co.kr) °á°ú: 0 ÆäÀÌÁö: 1
Á¦Ç°¸í
ÆÇ¸Å»ç
º¸ÇèÄÚµå ¼ººÐ/ÇÔ·®
±¸ºÐ/º¸Çè±Þ¿©
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference ¸ÂÃã °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - WebMD.com Drug Reference À¯»ç °Ë»ö (http://www.webmd.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition ¸ÂÃã °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - Drug.com Drugs by Medical Condition À¯»ç °Ë»ö (http://www.drugs.com) °á°ú: 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
KMLE À¥ ¿ë¾î À¯»ç °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
ÇÑ¿µ/¿µÇÑ »çÀü ¸ÂÃã °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
  • ¿µ¹®
    ÇѱÛ
WordNet ÀÏ¹Ý ¿µ¿µ »çÀü °Ë»ö °á°ú : 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü ¸ÂÃã °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
¿ÜºÎ ¸µÅ© - American Heritage Dictionary ¿µ¿µ»çÀü À¯»ç °Ë»ö (https://www.ahdictionary.com) °á°ú: 0 ÆäÀÌÁö: 1
ÅëÇÕ°Ë»ö ¿Ï·á